NMTR 9 Meters Biopharma, Inc.

9 Meters Biopharma, Inc. is a clinical-stage biopharmaceutical company. It focuses on developing novel medicines for autoimmune inflammatory disease. The company is founded by Jay P. Madan and Kendyle Woodard in 2012 and is headquartered in Raleigh, NC.

$0.22
As of 07/01/2022     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  07/08/2016
Outstanding shares:  259,107,380
Average volume:  6,364,429
Market cap:   $86,101,382
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BLB80L0

---

Valuation   (See tab for details)

---

PE ratio:   0.00
PB ratio:   2.17
PS ratio:   0.00
Return on equity:   -138.00%
Net income %:   0.00%